Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study. [electronic resource]
Producer: 20171102Description: 1007-1014 p. digitalISSN:- 1874-1754
- Acarbose -- adverse effects
- Administration, Oral
- Age Factors
- Aged
- Carbamates -- adverse effects
- Cohort Studies
- Confidence Intervals
- Databases, Factual
- Diabetes Mellitus, Type 2 -- diagnosis
- Female
- Follow-Up Studies
- Heart Failure -- etiology
- Hospital Mortality
- Hospitalization -- statistics & numerical data
- Humans
- Hypoglycemic Agents -- adverse effects
- Incidence
- Male
- Middle Aged
- Piperidines -- adverse effects
- Proportional Hazards Models
- Retrospective Studies
- Risk Assessment
- Sex Factors
- Sulfonylurea Compounds -- adverse effects
- Survival Rate
- Taiwan
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.